Art Mandell

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Brian Leaf, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Art Mandell:

Company Role Class Num Shares Value Price $ Report Date Ownership
MAXCYTE, INC. Director Common Stock 395,851 $1,940,066 $4.90 11 Jun 2024 Direct
MAXCYTE, INC. Director Stock Option (right to buy) 40,701 11 Jun 2024 Direct

Insider Reports Filed by Art Mandell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MXCT MAXCYTE, INC. 11 Jun 2024 2 $0 4 Director 13 Jun 2024, 17:41
MXCT MAXCYTE, INC. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 17:17
MXCT MAXCYTE, INC. 29 Jun 2022 1 $0 4 Director 08 Jul 2022, 16:02
MXCT MAXCYTE, INC. 09 Aug 2021 1 $0 4 Director 11 Aug 2021, 17:17
MXCT MAXCYTE, INC. 29 Jul 2021 0 $0 3 Director 29 Jul 2021, 18:41